JPM
JPMorgan Chase & Co.
JPM has the edge over MNSB overall, supported by stronger modeled upside and lower modeled downside.
MNSB
MainStreet Bancshares, Inc.
MNSB's outlook is improving, though it still trails on the overall score.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
MNSB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
MNSB's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like MNSB.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over MNSB in the historical PE scenario, which offers more potential upside but is not a forecast.
MNSB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.4x | $12.45 | -42% |
| Fair | 9.1x | $17.67 | -18% |
| Forward | 10x | $21.45 | — |
| Current | 11x | $21.45 | — |
| Expensive | 12x | $22.58 | +5.3% |
Historical ranges are pointers, not guarantees.
MNSB's PE is in its expensive range at 11x. If earnings grow as analysts expect, today's price would be 10x next year's earnings.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
MNSB Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for MNSB, with profitability holding steady.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over MNSB on earnings, with more consistent year-over-year improvement.
MNSB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.07 | +6.2% |
| Q3 2026 | $1.95 | +$2.84 |
| Q2 2026 | $2.04 | +$3.49 |
| Q1 2026 | $1.99 | +$3.70 |
| Q4 2025 | $1.76 | +$3.36 |
| Q3 2025 | -$0.89 | -174% |
| Q2 2025 | -$1.45 | -172% |
| Q1 2025 | -$1.71 | -166% |
| Q4 2024 | -$1.60 | -149% |
MNSB has returned to profit: it earned $1.95 per share over the past year, after losing money the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over MNSB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over MNSB on profitability, with a higher operating margin.
MNSB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19.4M | +6.7% |
| Q2 2026 | $19.1M | -3.7% |
| Q1 2026 | $17.9M | +2.6% |
| Q4 2025 | $18M | +7.1% |
| Q3 2025 | $18.2M | +12% |
| Q2 2025 | $19.9M | +23% |
| Q1 2025 | $17.4M | +7.3% |
| Q4 2024 | $16.8M | -5.7% |
MNSB's revenue has held roughly level: $19M last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | -5.8 points |
| Q2 2026 | 32% | +3 points |
| Q1 2026 | 30% | +12 points |
| Q4 2025 | 27% | +152 points |
| Q3 2025 | 30% | +29 points |
| Q2 2025 | 28% | +11 points |
| Q1 2025 | 18% | -7.5 points |
| Q4 2024 | -125% | -160 points |
MNSB's operating margin was 24% last quarter, down 5.8 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
MNSB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.8M | +6.4% |
| Q2 2026 | $4.8M | +$7.5M |
| Q1 2026 | $6.5M | +366% |
| Q4 2025 | $6.4M | +19% |
| Q3 2025 | $5.5M | +27% |
| Q2 2025 | -$2.6M | -345% |
| Q1 2025 | $1.4M | -54% |
| Q4 2024 | $5.4M | +1.8% |
MNSB has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has 2.7B diluted shares, down 3.1% from a year ago, with $24.5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
MNSB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -57.9K shares |
| 1 year | -7.6% | -585K shares |
| 3 years | -5.4% | -405K shares |
| 5 years | -6% | -452K shares |
| Available history | -14% | -1.1M shares |
MNSB has the edge over JPM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $5M |
| Q1 2026 | $6.1M |
| Q4 2025 | $3.9M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $446,000 |
| Q4 2024 | $13,000 |
MNSB spent $15M buying back its own shares over the past year, more than ten times what it spent the year before.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over MNSB on leverage, with a lower net debt burden relative to earnings.
MNSB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.5x | Healthy |
| Q4 2025 | 1.9x | Healthy |
| Q3 2024 | 1.9x | Healthy |
| Q2 2024 | 1.3x | Healthy |
| Q1 2024 | 0.8x | Very low |
| Q4 2023 | 0.5x | Very low |
MNSB's net debt is about 1.7 years of its operating earnings (EBITDA), down from 1.9 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MNSB.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
MNSB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.4 | Neutral |
| Stochastic | 16.6 | Oversold |
MNSB's weekly RSI is 38 (neutral) and its Stochastic is 17 (oversold).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
MNSB PE vs Financial Services Sector
| Metric | MNSB | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 16% below |
| PE % | 75 | 63 | 12 pts above |
MNSB has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over MNSB on trend strength, trading above more of its moving averages.
MNSB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.5 | 8.5% below |
| 20 week MA | $24.1 | 11% below |
| 50 week MA | $23.0 | 6.8% below |
| 100 week MA | $20.9 | 2.7% above |
| 200 week MA | $20.8 | 3.2% above |
MNSB has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 3.2% above its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over MNSB on returns for 2026, with the stronger performance.
MNSB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.0 | $16.8 | -27% |
| 2021 | $16.8 | $23.8 | +42% |
| 2022 | $23.8 | $27.4 | +15% |
| 2023 | $27.4 | $24.8 | -9.3% |
| 2024 | $24.8 | $18.0 | -27% |
| 2025 | $18.0 | $21.0 | +17% |
| 2026 YTD | $21.0 | $21.5 | +2.1% |
MNSB has finished lower in three of the last six years. It's up 2.1% so far in 2026.